193 related articles for article (PubMed ID: 26552455)
21. Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.
Lee JY; Kim N; Kim MS; Choi YJ; Lee JW; Yoon H; Shin CM; Park YS; Lee DH; Jung HC
Dig Dis Sci; 2014 Jun; 59(6):1235-43. PubMed ID: 24599773
[TBL] [Abstract][Full Text] [Related]
22. Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection.
Lim JH; Lee DH; Lee ST; Kim N; Park YS; Shin CM; Song IS
World J Gastroenterol; 2015 Dec; 21(46):13124-31. PubMed ID: 26673999
[TBL] [Abstract][Full Text] [Related]
23. Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children.
Kusano C; Gotoda T; Suzuki S; Ikehara H; Moriyama M
J Gastroenterol; 2018 Jun; 53(6):718-724. PubMed ID: 29110085
[TBL] [Abstract][Full Text] [Related]
24. Eradication Rate of
Liu RP; Romero R; Sarosiek J; Dodoo C; Dwivedi AK; Zuckerman MJ
South Med J; 2018 Jan; 111(1):51-55. PubMed ID: 29298370
[TBL] [Abstract][Full Text] [Related]
25. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
[TBL] [Abstract][Full Text] [Related]
26. Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
Gisbert JP; Pérez-Aisa A; Bermejo F; Castro-Fernández M; Almela P; Barrio J; Cosme A; Modolell I; Bory F; Fernández-Bermejo M; Rodrigo L; Ortuño J; Sánchez-Pobre P; Khorrami S; Franco A; Tomas A; Guerra I; Lamas E; Ponce J; Calvet X;
J Clin Gastroenterol; 2013 Feb; 47(2):130-5. PubMed ID: 22647827
[TBL] [Abstract][Full Text] [Related]
27. Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions.
Martos M; Bujanda L; Salicio Y; Sarasqueta C; Ibarra B; Mendarte U; Fernández-Reyes M; Cosme A
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1380-4. PubMed ID: 25229983
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
[TBL] [Abstract][Full Text] [Related]
29. Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
Branquinho D; Almeida N; Gregório C; Cabral JE; Casela A; Donato MM; Tomé L
BMC Gastroenterol; 2017 Feb; 17(1):31. PubMed ID: 28202013
[TBL] [Abstract][Full Text] [Related]
30. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
31. Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?
Almeida N; Donato MM; Romãozinho JM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Fernandes A; Calhau C; Sofia C
BMC Gastroenterol; 2015 Feb; 15():23. PubMed ID: 25886722
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
Ozturk O; Doganay L; Colak Y; Yilmaz Enc F; Ulasoglu C; Ozdil K; Tuncer I
Arab J Gastroenterol; 2017 Jun; 18(2):62-67. PubMed ID: 28601610
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori eradication: sequential therapy and Lactobacillus reuteri supplementation.
Efrati C; Nicolini G; Cannaviello C; O'Sed NP; Valabrega S
World J Gastroenterol; 2012 Nov; 18(43):6250-4. PubMed ID: 23180945
[TBL] [Abstract][Full Text] [Related]
35. Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice.
Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Mochizuki S; Matsuo K; Isomura Y; Seto M; Suzuki N; Suzuki H; Yamamoto S; Sugimoto T; Omae T; Okamoto M; Watabe H; Togo G; Takano N; Fukui K; Ito Y; Koike K
J Dig Dis; 2016 Oct; 17(10):670-675. PubMed ID: 27534444
[TBL] [Abstract][Full Text] [Related]
36. Quadruple therapy for eradication of Helicobacter pylori.
Ma HJ; Wang JL
World J Gastroenterol; 2013 Feb; 19(6):931-5. PubMed ID: 23429422
[TBL] [Abstract][Full Text] [Related]
37. [The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in
Kwon S; Lee DH; Kang JB; Kim N; Park YS; Shin CM; Yoon H; Choi YJ
Korean J Gastroenterol; 2017 Aug; 70(2):72-80. PubMed ID: 28830132
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital.
Dib J; Alvarez B; Mendez L; Cruz ME
Arab J Gastroenterol; 2013 Sep; 14(3):123-5. PubMed ID: 24206741
[TBL] [Abstract][Full Text] [Related]
39. The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.
Basyigit S; Kefeli A; Sapmaz F; Yeniova AO; Asilturk Z; Hokkaomeroglu M; Uzman M; Nazligul Y
Bosn J Basic Med Sci; 2015 Oct; 15(4):50-4. PubMed ID: 26614852
[TBL] [Abstract][Full Text] [Related]
40. [Trends in the eradication rates of Helicobacter pylori infection in Daegu and Gyeongsangbuk-do, Korea: multicenter study over 13 years].
Jung YS; Lee SH; Park CS; Oh MJ; Kim KO; Jang BI; Jeon SW; Jung MK; Park KS; Kim ES; Cho KB; Jung JT; Kwon JG; Kim EY; Kim WJ; Yang CH
Korean J Gastroenterol; 2014 Feb; 63(2):82-9. PubMed ID: 24561694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
